CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Capital Adjusts Gilead Sciences Price Target to $120 From $122, Maintains Sector Perform Rating

Neutral
AI Analysis

Summary

RBC Capital adjusted Gilead Sciences price target downward to $120 from $122 while maintaining a Sector Perform rating.

Importance:2/10
Sentiment:
-0.10
price target adjustmentanalyst ratingsector perform
Related Companies

Read the original article

Published by yahoo_finance on July 7, 2026 11:18 AM

Read Original